These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 22982598)

  • 1. Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells.
    Ribeiro M; Rosenstock TR; Cunha-Oliveira T; Ferreira IL; Oliveira CR; Rego AC
    Free Radic Biol Med; 2012 Nov; 53(10):1857-67. PubMed ID: 22982598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of 3-alkyl luteolin derivatives are mediated by Nrf2 transcriptional activity and decreased oxidative stress in Huntington's disease mouse striatal cells.
    Oliveira AM; Cardoso SM; Ribeiro M; Seixas RS; Silva AM; Rego AC
    Neurochem Int; 2015 Dec; 91():1-12. PubMed ID: 26476055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells--protective effect of cystamine and creatine.
    Ribeiro M; Silva AC; Rodrigues J; Naia L; Rego AC
    Toxicol Sci; 2013 Dec; 136(2):487-99. PubMed ID: 24008831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells.
    Ribeiro M; Rosenstock TR; Oliveira AM; Oliveira CR; Rego AC
    Free Radic Biol Med; 2014 Sep; 74():129-44. PubMed ID: 24992836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease.
    Li X; Valencia A; Sapp E; Masso N; Alexander J; Reeves P; Kegel KB; Aronin N; Difiglia M
    J Neurosci; 2010 Mar; 30(13):4552-61. PubMed ID: 20357106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.
    Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM
    Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
    Hansson O; Castilho RF; Korhonen L; Lindholm D; Bates GP; Brundin P
    J Neurochem; 2001 Aug; 78(4):694-703. PubMed ID: 11520890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dithiol-based compounds maintain expression of antioxidant protein peroxiredoxin 1 that counteracts toxicity of mutant huntingtin.
    Pitts A; Dailey K; Newington JT; Chien A; Arseneault R; Cann T; Thompson LM; Cumming RC
    J Biol Chem; 2012 Jun; 287(27):22717-29. PubMed ID: 22577145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.
    Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B
    J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 transglutaminase differentially modulates striatal cell death in the presence of wild type or mutant huntingtin.
    Ruan Q; Quintanilla RA; Johnson GV
    J Neurochem; 2007 Jul; 102(1):25-36. PubMed ID: 17403029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo.
    Graham RK; Deng Y; Carroll J; Vaid K; Cowan C; Pouladi MA; Metzler M; Bissada N; Wang L; Faull RL; Gray M; Yang XW; Raymond LA; Hayden MR
    J Neurosci; 2010 Nov; 30(45):15019-29. PubMed ID: 21068307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.
    Ju TC; Chen HM; Chen YC; Chang CP; Chang C; Chern Y
    Biochim Biophys Acta; 2014 Sep; 1842(9):1668-80. PubMed ID: 24946181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.
    Kuhn A; Goldstein DR; Hodges A; Strand AD; Sengstag T; Kooperberg C; Becanovic K; Pouladi MA; Sathasivam K; Cha JH; Hannan AJ; Hayden MR; Leavitt BR; Dunnett SB; Ferrante RJ; Albin R; Shelbourne P; Delorenzi M; Augood SJ; Faull RL; Olson JM; Bates GP; Jones L; Luthi-Carter R
    Hum Mol Genet; 2007 Aug; 16(15):1845-61. PubMed ID: 17519223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK506 ameliorates cell death features in Huntington's disease striatal cell models.
    Rosenstock TR; de Brito OM; Lombardi V; Louros S; Ribeiro M; Almeida S; Ferreira IL; Oliveira CR; Rego AC
    Neurochem Int; 2011 Oct; 59(5):600-9. PubMed ID: 21703318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis.
    Reis SA; Thompson MN; Lee JM; Fossale E; Kim HH; Liao JK; Moskowitz MA; Shaw SY; Dong L; Haggarty SJ; MacDonald ME; Seong IS
    Hum Mol Genet; 2011 Jun; 20(12):2344-55. PubMed ID: 21447599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant-like responses in the forced swimming test elicited by glutathione and redox modulation.
    Rosa JM; Dafre AL; Rodrigues AL
    Behav Brain Res; 2013 Sep; 253():165-72. PubMed ID: 23850355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute exposure to chlorpyrifos caused NADPH oxidase mediated oxidative stress and neurotoxicity in a striatal cell model of Huntington's disease.
    Dominah GA; McMinimy RA; Kallon S; Kwakye GF
    Neurotoxicology; 2017 May; 60():54-69. PubMed ID: 28300621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
    Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ
    Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice.
    Lloret A; Dragileva E; Teed A; Espinola J; Fossale E; Gillis T; Lopez E; Myers RH; MacDonald ME; Wheeler VC
    Hum Mol Genet; 2006 Jun; 15(12):2015-24. PubMed ID: 16687439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of HTT inclusion size, location, and timing in the zQ175 mouse model of Huntington's disease: an in vivo high-content imaging study.
    Carty N; Berson N; Tillack K; Thiede C; Scholz D; Kottig K; Sedaghat Y; Gabrysiak C; Yohrling G; von der Kammer H; Ebneth A; Mack V; Munoz-Sanjuan I; Kwak S
    PLoS One; 2015; 10(4):e0123527. PubMed ID: 25859666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.